106 related articles for article (PubMed ID: 17487858)
1. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Trivanovic D; Petkovic M; Stimac D
Cancer; 2007 Jun; 109(12):2623-4; author reply 2624. PubMed ID: 17487858
[No Abstract] [Full Text] [Related]
2. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
3. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of serum levels of tumour markers and prognosis of recurrence and survival after liver surgery for colorectal liver metastases.
Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Kormunda S; Pesta M; Finek J; Rousarova M; Topolcan O
Anticancer Res; 2007; 27(4C):2861-4. PubMed ID: 17695461
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic yield of tumor markers in cancer of unknown primary site.
Parvez T; Ibraheim MI
J Coll Physicians Surg Pak; 2006 Feb; 16(2):154-6. PubMed ID: 16499817
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers as useful predictors of survival rate after exploratory laparotomy for liver malignancies.
Liska V; Holubec L; Treska V; Skalicky T; Sutnar A; Topolcan O; Kormunda S; Finek J
Anticancer Res; 2007; 27(4A):1887-91. PubMed ID: 17649789
[TBL] [Abstract][Full Text] [Related]
7. Hormone receptor status as a prognostic factor in breast cancer patients with hepatic metastases treated by liver resection.
Purnak T; Altundag K
Ann Surg; 2007 Aug; 246(2):338; author reply 338. PubMed ID: 17667517
[No Abstract] [Full Text] [Related]
8. [Unknown primary tumour--diagnostic strategies and treatment].
Møller AK; Gundgaard MG; Petersen BL; Daugaard G
Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
[TBL] [Abstract][Full Text] [Related]
9. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
11. Tumour markers in cancers of unknown primary: a clinical perspective.
Savage P
Ann Clin Biochem; 2006 Jan; 43(Pt 1):1-2. PubMed ID: 16390602
[No Abstract] [Full Text] [Related]
12. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
Onofre AS; Pomjanski N; Buckstegge B; Böcking A
Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
[TBL] [Abstract][Full Text] [Related]
13. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
[TBL] [Abstract][Full Text] [Related]
15. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
Katsuno H; Zacharakis E; Aziz O; Rao C; Deeba S; Paraskeva P; Ziprin P; Athanasiou T; Darzi A
Ann Surg Oncol; 2008 Nov; 15(11):3083-91. PubMed ID: 18787906
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in unknown primary cancer.
Culine S
Semin Oncol; 2009 Feb; 36(1):60-4. PubMed ID: 19179189
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in cancer of unknown primary site.
Fernandez-Cotarelo MJ; Guerra-Vales JM; Colina F; de la Cruz J
Tumori; 2010; 96(1):111-6. PubMed ID: 20437867
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer.
Noike T; Miwa S; Soeda J; Kobayashi A; Miyagawa S
Hum Pathol; 2008 Feb; 39(2):201-8. PubMed ID: 17949784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
